SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bafna Pharmaceuticals submits copy of limited review report

11 Aug 2014 Evaluate

Bafna Pharmaceuticals has submitted a Copy of the Limited Review Report for the period ended June 30, 2014.

The above information is a part of company’s filings submitted to BSE.

Bafna Pharmaceutical Share Price

225.05 -4.55 (-1.98%)
02-Jul-2026 13:16 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1870.90
Dr. Reddys Labs. 1350.65
Cipla 1459.55
Zydus Lifesciences 1099.00
Lupin 2394.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: